
Norditropin’s Safety and Efficacy in American Males with Turner Syndrome: A Clinical Trial
Reading Time: 2 minutes Introduction Turner syndrome, traditionally identified in females, can also manifest in males due to mosaicism or other genetic variations. Norditropin, a recombinant human growth hormone, has been pivotal in managing growth-related issues in various conditions. This article delves into a multi-center clinical trial assessing the safety and tolerability of Norditropin in American males with Turner syndrome, shedding light on its potential benefits and risks. Study Design and Methodology The clinical trial involved a cohort of American males diagnosed with Turner syndrome across multiple centers in the United States. Participants were administered Norditropin at varying dosages based on their individual needs...